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A b s t r a c t
Coronary angiography is the current gold standard for the diagnosis of ischemic heart disease and therefore the prevalence of
percutaneous coronary procedures such as angiography and angioplasty is high. The occurrence of cerebral complications after coro-
nary angiography and coronary angioplasty is low and it mainly includes transient ischemic attack and stroke. The prevalence of tran-
sient cortical blindness after X-ray contrast media is low and it is usually seen after cerebral angiography. Until now only a few cas-
es of transient cortical blindness have been described after coronary artery angiography. Regarding the spread of coronary angiography
worldwide and in Poland this complication is uniquely rare. A 32-year-old man with multiple extrasystolic ventricular arrhythmia sug-
gesting Brugada syndrome diagnosis according to morphology of the left bundle branch block and with decreased left ventricular ejec-
tion fraction was admitted to the First Department of Cardiology and Hypertension, Medical College of the Jagiellonian University in
Krakow. Coronary angiography was performed in order to exclude ischemic etiology of the observed abnormalities. No arterioscle-
rotic lesions were found in coronary arteries. Transient cortical blindness was observed directly after angiography which may have
been caused by the neurotoxic effect of the used X-ray contrast medium. In ophthalmologic and neurologic examination as well as
in the cerebral computed tomography scan no pathologies were found. Visual impairment disappeared totally within several hours. 
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S t r e s z c z e n i e
Koronarografia jest obecnie złotym standardem w diagnostyce choroby niedokrwiennej serca, w związku z czym częstość wyko-
nywania przezskórnych zabiegów wieńcowych, tj. angiografii oraz angioplastyki, jest duża. Powikłania naczyniowo-mózgowe po koro-
narografii i koronaroplastyce są rzadkie i zazwyczaj obejmują przejściowe ataki niedokrwienne oraz udary mózgu. Częstość występo-
wania przejściowych korowych zaburzeń widzenia po środkach kontrastowych jest niewielka. Zaburzenia te stwierdza się zazwyczaj
w przypadku angiografii naczyń mózgowych. Przemijające korowe zaburzenia widzenia po zabiegu koronarografii opisano dotychczas
jedynie u kilkunastu pacjentów. Biorąc pod uwagę szerokie i częste zastosowanie koronarografii na świecie, a także w Polsce, jest to
więc wyjątkowo rzadkie powikłanie. Do I Kliniki Kardiologii i Nadciśnienia Tętniczego Szpitala Uniwersyteckiego w Krakowie przyjęto
32-letniego chorego z licznymi pobudzeniami dodatkowymi o morfologii bloku lewej odnogi pęczka Hisa, ze zmianami w spoczyn-
kowym badaniu elektrokardiograficznym sugerującymi podejrzenie zespołu Brugadów, a także z obniżoną frakcją wyrzutową lewej
komory serca. W celu wykluczenia podłoża niedokrwiennego obserwowanych nieprawidłowości chorego zakwalifikowano do koro-
narografii. W wykonanym badaniu nie stwierdzono zmian w tętnicach wieńcowych. Przebieg zabiegu był powikłany przejściowymi
korowymi zaburzeniami widzenia, które odniesiono do neurotoksycznego działania kontrastu. W przeprowadzonej wówczas tomo-
grafii komputerowej mózgowia nie zaobserwowano patologii, a w badaniu okulistycznym i neurologicznym nie odnotowano przyczyn
zgłaszanych dolegliwości. Zaburzenia widzenia ustąpiły samoistnie w ciągu kilkunastu godzin. 
Słowa kluczowe: ślepota korowa, środki kontrastowe, koronarografia.
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Introduction
Coronary angiography is currently the gold standard in
the detection of ischemic heart disease, which is why per-
cutaneous procedures such as angiography or percutaneous
coronary intervention (PCI) are frequently performed. Ce re-
brovascular complications of coronary angiography and PCI
are rare and usually include transient ischemic attacks (TIA)
or stroke and affect approximately 0.4% of all pa tients under-
going PCI [1, 2]. These complications occur more often in some
specific groups of patients: in the elderly, in female patients,
in patients with diabetes mellitus type 2, in those with dif-
fuse atherosclerosis, in patients undergoing coronary artery
bypass grafting, in patients with peri-procedural complica-
tions (artery dissection) and in patients with no-reflow who
often require intra-aortic counterpulsation [2]. 
Cortical visual impairment following administration of
a contrast agent occurs in 0.3-1.0% of patients undergoing
angiography of the cerebral arteries [3]. In the case of coro-
nary angiography the rate is 0.21-0.45% [4]. This is a very
rare complication given the widespread and frequent use
of coronary angiography throughout the world, including
Poland (around 3500 procedures/million inhabitants) [5].
Patients at risk of cortical visual impairment include those
after previous coronary artery bypass grafting and patients
with renal failure. The exact mechanism leading to the onset
of cortical visual impairment remains unknown. The most
likely explanation of this phenomenon is an increase of per-
meability of the blood-brain barrier and a direct neurotoxic
effect of contrast agents [6, 7]. 
Aim
The aim of the study was to present a case of a tran-
sient cortical visual impairment after coronary angiography
in a patient admitted to diagnose the causes of arrhythmia.
Case report
A 32-year-old patient suspected of having Brugada syn-
drome (syncope with complete loss of consciousness, J point
elevation in leads V1-V3 on resting electrocardiogram and
sudden cardiac death of the father at the age of 49 years),
with right ventricular extrasystoles was admitted to the 1st
Department of Cardiology and Hypertension of the University
Hospital in Cracow for the ajmaline challenge. The result of
the study was inconclusive for the Brugada syndrome.
Because of decreased left ventricular ejection fraction on
echocardiography (EF around 40%) the patient was quali-
fied for coronary angiography, which did not reveal changes
in coronary arteries (Figure 1). Coronary angiography was per-
formed through the right femoral artery with a 6 F vascu-
lar sheath and Judkins diagnostic catheters and was pre-
ceded by local anesthesia with 1% lignocaine solution. The
procedure lasted 20 min and the patient remained hemo-
dynamically stable for the whole time. Approximately
100 ml of a nonionic, hypo-osmolar contrast agent (Utrav-
ist) was used for the procedure. The patient did not have
a history of previous procedures with contrast medium
administration. During coronary angiography the patient
reported visual impairment without any other focal symp-
toms. In 15 min time the patient completely lost vision. He
was conscious, with good verbal contact, good auto- and
allopsychic orientation and good respiratory and circulatory
condition (during the procedure and immediately after the
procedure blood pressure was 130/80 mm Hg, heart
rhythm 60 bmp). Directly after the coronary angiography
the patient underwent neurological and ophthalmological
consultation. Apart from binocular blindness there were no
other abnormalities. Urgently performed computed tomog-
raphy of the head (without contrast medium) did not reveal
any pathology (Figure 2). Visual impairment resolved com-
pletely on the first day after the coronary angiography. 
Based on the clinical picture (numerous ventricular
extrasystoles with LBBB morphology, akinetic area within
the right ventricular free wall and reduced right ventricu-
lar ejection fraction (40%) on magnetic resonance imaging
(MRI) with reduced left ventricular ejection fraction on
echocardiography and sudden, unexplained death of the
father) a diagnosis of idiopathic dilated cardiomyopathy was
made, which may be an early manifestation of arrhyth-
mogenic right ventricular cardiomyopathy with left ven-
tricular involvement. However, during the stay in the clin-
ic there was no clear evidence favoring the diagnosis of
arrhythmogenic right ventricular cardiomyopathy. Genet-
ic samples were obtained from the patient to test for arrhyth-
mogenic right ventricular cardiomyopathy and Brugada syn-
drome and they are currently under determination. The
patient was discharged home on the third day after the coro-
nary angiography in a good general condition and without
any symptoms. 
Discussion
In the presented case the differential diagnosis should
primarily include the occurrence of arrhythmias in a patient
with a history of recurrent syncope and arrhythmia and
a secondary ischemia of the central nervous system.
However, on the coronary angiography and in the follow-
ing hours the patient was under constant ECG, blood pres-
sure and blood oxygenation monitoring. No abnormalities
were recorded. As the next step it should be assumed that
the described reaction had an allergic or non-allergic
hypersensitivity character after administered pharmaco-
logical agents. The patient received 2% lignocaine solution
(subcutaneous administration before the procedure) and
a nonionic low-osmolar intravenous contrast agent. Side
effects observed after local application of anesthetic
agents occur within several, maximally 20 min following
administration. These include dizziness, psychomotor agi-
tation, excessive sweating, tachycardia, double vision, tin-
nitus, body tremor, slurred speech and fainting. They are
usually associated with drug overdose or accidental admin-
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istration of the drug directly into the vessel [8]. It seems that
the described loss of vision should not be related to the use
of lignocaine, although there are isolated reports on such
a complication in the literature [9]. In our patient clinical
symptoms occurred after approximately 30 min of local anes-
thesia, and had a clear temporal relationship with the admin-
istration of the nonionic contrast agent. Intravenous con-
trast agents are highly concentrated solutions of low
molecular weight. They diffuse out of the bloodstream at
a rapid pace and 70% of the dose disappears from plasma
within about 2-5 min after the administration [8]. Epi-
demiologic studies conducted in the 1980s demonstrated
that the frequency of adverse reactions after injection of
nonionic low-osmolar contrast agents is 0.7-3.1%, of which
life-threatening reactions account for 0.02-0.04% of cases
[8]. Most adverse reactions are characterized by a low inten-
sity and are associated with non-specific (non-allergic) influ-
ence of the agent particles directly on the cellular mem-
branes [8]. These are most often mastocytes, present in the
skin and in the connective tissue, which undergo activa-
tion and degranulation. It results in anaphylactic reaction
with the presence of skin changes and symptoms of res-
piratory, gastrointestinal and circulatory system involvement.
The symptoms of central nervous system involvement
include syncope and seizures, which are related to cerebral
ischemia. None of the typical symptoms suggesting the pres-
ence of an anaphylactic reaction were present in our patient.
The pathophysiology of transient cortical visual impair-
ment is not clear. Most likely, the blood-brain barrier becomes
damaged, which allows the contrast agent to express a direct
neurotoxic effect on nerve cell membranes in the occipital
lobes [1]. In the majority of cases described so far, the com-
puted tomography image showed post-contrast enhance-
ment in the occipital lobe, which may be related to body
position during coronary angiography. Additionally it was
demonstrated that posterior cerebral circulation is most sus-
ceptible to the above pathologies, which may result from
difference in sympathetic innervation [10, 11]. The risk of
transient cortical blindness increases with the use of
highly osmolar contrast agents, but the complication may
also occur after application of nonionic, low-osmolar sub-
stances [12], as in our case. According to the data from the
drug registration office the possible complications involv-
Fig. 1. Coronary angiography
Ryc. 1. Badanie koronarograficzne
Fig. 2. Computed tomography
Ryc. 2. Badanie tomograficzne głowy
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ing the central nervous system and related to Ultravist (iopro-
mide) use include dizziness, headache, confusion or agitation,
amnesia, impaired speech, hearing and vision as well as
transient blindness. These abnormalities occur more fre-
quently in patients with previously diagnosed disease of the
central nervous system and in patients undergoing angiog-
raphy of the cerebral arteries. In the latter situation con-
centration of the contrast agent in the cerebral circulation
is higher [13]. The risk factors also include renal failure and
coronary bypass from the internal mammary artery (the ori-
gin of the internal mammary artery from the subclavian
artery close to the origin of the vertebral artery may favor
the passage of a large amount of contrast agent to the left
vertebral artery during bypassography of the left internal
mammary artery) [6, 7]. Our patient was not at risk of cor-
tical visual impairment. However, based on the family his-
tory and clinical observation it is possible that he might have
a congenital defect of ion channels of the cellular membranes,
which might cause abnormalities in the electrical activity of
neurons, and thus the conduction of nerve impulses.
An attempt to characterize the clinical features of
patients with documented cortical visual impairment was
made by Frantz during the EuroPCR congress in 2006 [6].
The presented data included 15 patients and suggested
a higher prevalence of the complication in men than in
women. The mean age of patients in the study was 54 ±7.6
years, more than half of them had confirmed arterial hyper-
tension (9 patients), 1 patient had impaired renal function
and 9 patients had a history of exposure to contrast agents.
The amount of contrast medium used for the procedures
ranged from 75 ml to 400 ml. Return to normal vision last-
ed from 15 min to 5 days. 
A differential diagnosis of transient cortical visual
impairment after coronary angiography should include cere-
bral embolism, cerebral vasospasm, hysterical blindness and
post-contrast hypotension [6]. 
There is no determined management strategy for this
complication. Neurological and ophthalmological consultation
and imaging examinations of the brain (computed tomog-
raphy and magnetic resonance) are necessary for the diag-
nosis. Strict control of blood pressure and diuresis seem to
be relevant in the fast resolution of symptoms, although
there are no data on the influence of hydration or fluid ther-
apy and diuresis control on the described complication.
Conclusions
Transient cortical visual impairment is a rare, rapidly pro-
gressing complication of angiography. Although the exact
mechanism of cortical visual impairment in unknown, the
interruption of the blood-brain barrier and direct neurotoxic
effect of contrast agent are the most likely causes of this
abnormality. Neurological and ophthalmological consulta-
tion and imaging examinations of the brain (computed
tomography and magnetic resonance) seem necessary for
the diagnosis. Currently, there is no determined manage-
ment strategy for this complication.  
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